New opioid guideline for chronic non-cancer pain focuses on preventing harm

May 8, 2017, Canadian Medical Association Journal
Credit: CC0 Public Domain

A new guideline for prescribing opioids for people with chronic non-cancer pain is aimed at helping health care professionals in Canada limit use of these addictive and potentially lethal drugs. The guideline, published in CMAJ (Canadian Medical Association Journal) contains 10 recommendations, of which 7 are focused on preventing harm from opioid use.

"Opioids are not first-line treatment for chronic non-cancer pain, and should only be considered after non- has been optimized," says guideline lead Jason Busse, an associate professor of anesthesia at the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont., and researcher for the National Pain Centre. "There are important risks associated with opioids, such as unintentional overdose, and these risks increase with higher doses."

Chronic non-cancer pain is defined as pain lasting more than three months that negatively affects quality of life and interferes with daily activities. An estimated 15% to 19% of Canadians experience this type of pain.

This guideline incorporates all new evidence published since the last guideline was issued in 2010. An innovative approach was taken in developing the guideline, with involvement from across Canada, clinicians with expertise in pain management and diverse views on the role of opioids, as well as researchers.

The guideline does not address prescribing for patients with pain due to cancer, or those with opioid addiction or opioid use disorder.

Canada has the second highest rate of opioid prescribing in the world, and the highest when measuring daily doses. Hospital visits for opioid overdoses as well as fatalities have continued to rise in recent years.

The recommendations for health care providers focus on minimizing harm in a range of patients with chronic non-cancer pain, including people with current or past substance use disorders, other psychiatric disorders, and persistent pain despite opioid therapy.

Key recommendations:

  • Maximize non-opioid treatment: When considering therapy for people with chronic non-cancer pain, the guideline recommends optimizing non-opioid pharmaceutical as well as non-pharmaceutical therapy before considering opioids to avoid dependence, addiction and unintentional overdose.
  • Pain despite optimimal non-opioid treatment: For people with chronic pain despite opioid therapy optimization and without substance use disorders or other psychiatric issues, the guideline suggests a trial of opioids.
  • Opioid dosing: For people beginning opioid treatment, the guideline recommends restricting dosing to less than 90 mg morphine equivalents of opioids per day and ideally less than 50 mg, rather than having no upper limit for prescribing.
  • Opioid tapering: For patients currently using 90 mg morphine equivalents of opioids per day or more, the guideline suggests tapering to the lowest effective dose, and possibly discontinuing. Tapering can be paused or discontinued in patients who develop a substantial increase in pain or decrease in function persisting more than one month after a dose reduction.

"Canadian physicians' awareness of and adherence to the 2010 Canadian guideline recommendations for use of opioids to manage chronic pain have been limited," write the authors. "We have formally explored barriers to implementation and used the findings (e.g., excessive length of guidelines) to guide design and format of the current guideline."

The guideline and related material may be found at There is also an app available at to help physicians and patients work through shared decision-making on the topic.

The new guideline is consistent with the 2016 United States Centers for Disease Control and Prevention (CDC) guideline's recommendations around dose escalation. It differs, however, in the involvement of clinical experts with diverse views toward opioids for chronic non-cancer pain, a dedicated patient advisory committee, restricting recommendations to only areas in which sufficient evidence exists, and in only allowing panel members without important financial or intellectual conflicts of interest to vote on recommendations.

"Guidelines are not self-implementing, and there is an important lesson to be learned from the limited impact of the 2010 guideline. Publication of the 2017 guideline must be accompanied by a dedicated knowledge transfer and implementation strategy if it is to play an important role in addressing Canada's opioid crisis," said Dr. Busse.

The guideline group is seeking funding to help communicate these opioid prescribing guidelines and ensure widespread uptake and application of the recommendations.

In a related commentary, Drs. Andrea Furlan, Toronto Rehabilitation Institute, and Owen Williamson, Monash University, Melbourne, Australia, write that the aim of the updated guideline " ... is to promote safer and more effective opioid prescribing to the small proportion of patients with chronic noncancer pain who may benefit from their use, and this may well be achieved."

However, the opioid crisis will not be solved without a national strategy that offers non-opioid pain relief for people with long-term pain.

"The updated guideline will not address the public health crisis related to opioids without support from a comprehensive national strategy to ensure evidence-based alternative treatments for the one in five Canadians currently living with ," write the commentary authors.

Explore further: Physicians respond to new CDC opioid guidelines

Related Stories

Physicians respond to new CDC opioid guidelines

March 21, 2016
(HealthDay)—Physicians have responded to the new U.S. Centers for Disease Control and Prevention's clinical guidelines for prescribing opioids, according to a report published by the American Medical Association (AMA).

Guidelines developed for pain management in cancer survivors

July 26, 2016
(HealthDay)—Guidelines have been developed for chronic pain management in adult cancer survivors. The American Society of Clinical Oncology Clinical Practice Guideline was published online July 25 in the Journal of Clinical ...

Study finds opioid prescribing guideline significantly decreases prescription rates

December 29, 2015
Emergency medicine physicians at Temple University Hospital have found that an opioid prescribing guideline had an immediate and sustained impact on opioid prescribing rates for minor conditions and chronic noncancer pain ...

Opioid prescribing declines following release of national guidelines for physicians

December 14, 2016
The rate of opioid use in Canada has fallen 13.7 per cent since the publication in May 2010 of national guidelines for their use in chronic non-cancer pain, a new study has found.

Better quality of care may reduce risk of death for patients on opioid painkillers

February 4, 2016
Better quality of care may reduce the risk of death for patients who are prescribed opioid painkillers for chronic pain, say Yale researchers. Their study, published Feb. 4 in the Journal of General Internal Medicine, offers ...

Recommended for you

Medicating for mental health—Intense exercise before taking a daily dose could prevent weight gain, diseases

March 21, 2018
Weight gain and Type 2 diabetes are potential side effects in people taking a common medication to treat mental illness.

Certain teens more likely to get hooked on opioids

March 12, 2018
(HealthDay)—Teenagers with any mental health problem are more prone to painkiller dependence after receiving a prescription opioid, a new study finds.

Prescription opioids fail rigorous new test for chronic pain

March 6, 2018
A yearlong study offers rigorous new evidence against using prescription opioids for chronic pain.

Study suggests failed osteoarthritis drug could help treat opioid addiction

February 27, 2018
A new study from Indiana University suggests that a drug proven safe for use in people may prevent opioid tolerance and physical dependence when used in combination with opioid-based pain medications.

Complex inhalers prevent patients from taking medicine

February 23, 2018
Respiratory disease patients with arthritis could struggle to manage their conditions because their inhalers are too fiddly for them to use, University of Bath research has found.

Opioid abuse leads to heroin use and a hepatitis C epidemic, researcher says

February 22, 2018
Heroin is worse than other drugs because people inject it much sooner, potentially resulting in increased risk of injection-related epidemics such as hepatitis C and HIV, a Keck School of Medicine of USC study shows.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.